Can oestradiol pretreatment be used to reliably avoid weekend oocyte retrievals?

Reproductive BioMedicine Online

Volumn 24, Issue 5, 2012, Pages 487-489

  Griesinger, G ^a   Kolibianakis, E M ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

GnRH antagonist; oestradiol; ovarian stimulation; pretreatment; treatment scheduling; weekends

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL VALERATE; GONADOTROPIN;

HUMAN; MENSTRUATION; OOCYTE; OOCYTE MATURATION; OOCYTE RETRIEVAL; REVIEW; ULTRASOUND;

EID: 84861092921     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.01.026     Document Type: Note

References (15)

1. Blockeel, C., Engels, S., De Vos, M., Haentjens, P., Polyzos, N.P., Stoop, D., Camus, M., Devroey, P., 2011. Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. Reprod. BioMed. Online. doi:10.1016/j.rbmo.2011.11.012.
2. G. Borm, and B. Mannaerts Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group Hum. Reprod. 15 2000 1490 1498 (Erratum in: Hum. Reprod. 15 (2000) 1877)
3. European and Middle East Orgalutran Study Group Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation Hum. Reprod. 16 2001 644 651
4. B.C. Fauser, M.M. Alper, W. Ledger, W.B. Schoolcraft, A. Zandvliet, B.M. Mannaerts Engage Investigators Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF Reprod. Biomed. Online 21 2010 593 601
5. F. Fischl, J.C. Huber, and A. Obruca Zeitliche Optimierung der kontrollierten Hyperstimulation (KOH) in Kombination mit GnrH-Antagonisten und Ovulationshemmer in einem IVF-Programm J. Fertil. Reprod. 11 2001 50 51
6. K. Gordon, M.J. Levy, W. Ledger, E.M. Kolibianakis, and P.C. IJzerman-Boon Reducing the incidence of weekend oocyte retrievals in a rFSH/GnRH antagonist protocol by optimizing the start day of rFSH and delaying human chorionic gonadotropin (hCG) by 1 day Fertil. Steril. 95 2011 S16
7. G. Griesinger, C. Venetis, T. Marx, K. Diedrich, B. Tarlatzis, and E.M. Kolibianakis Oral contraceptive pill pre-treatment in ovarian stimulation with GnRH-antagonists for IVF: a systematic review and meta-analysis Fertil. Steril. 90 2008 1055 1063
8. G. Griesinger, E.M. Kolibianakis, C. Venetis, K. Diedrich, and B. Tarlatzis Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis Fertil. Steril. 94 2010 2382 2384
9. A. Guivarc'h-Levêque, P. Arvis, J.L. Bouchet, P.L. Broux, L. Moy, G. Priou, J. Vialard, and D. Colleu Efficiency of antagonist IVF cycle programming by estrogens Gynecol. Obstet. Fertil. 38 2010 18 22
10. A. Guivarc'h-Levêque, L. Homer, P. Arvis, P.L. Broux, L. Moy, G. Priou, J. Vialard, D. Colleu, and D. Dewailly Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes? Fertil. Steril. 96 2011 872 876
11. T. Hillensjo, T. Yeko, H. Witjes, J. Elbers, P. Devroey on behalf of the Engage investigators Does treatment flexibility affect clinical outcome of either corifollitropin alfa or daily rFSH regimens? Hum. Reprod. 26 Suppl. 1 2011 i296 i336 (P-468)
12. D. Kyrou, E.M. Kolibianakis, H.M. Fatemi, B.C. Tarlatzis, H. Tournaye, and P. Devroey Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH)antagonists? A prospective randomized trial Fertil. Steril. 96 2011 1112 1115
13. T. Mardešiè, M. Abuzeid, H. Witjes, and B. Mannaerts Success rates of early responders to corifollitropin alfa or daily rFSH in a large, randomized, double-blind trial Hum. Reprod. 26 Suppl. 1 2011 i296 i336 (P-469)
14. L. Rombauts, D. Healy, R.J. Norman Orgalutran Scheduling Study Group A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients Hum. Reprod. 21 2006 95 103 (Epub 2005 Oct 27. Erratum in: Hum. Reprod. 21 (2006) 3032)
15. K.P. Tremellen, and M. Lane Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes Hum. Reprod. 25 2010 1219 1224